PD-L1 expression level distribution was 27.1% with tumor proportion score (TPS) <1%, 49.5% with TPS 1%-49%, and 23.2% with TPS ≥50% (1 patient [0.2%] was not tested). The gene discussed is CD274; the disease is neoplasm.